Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice
Open Access
- 1 July 2003
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 4 (1), 31-39
- https://doi.org/10.1016/s1535-6108(03)00168-5
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL61371, HL64793, RO1 HL57665)
- Canadian Institutes of Health Research
This publication has 20 references indexed in Scilit:
- Regulation of Vascular Endothelial Growth Factor Receptor-2 Activity by Caveolin-1 and Plasma Membrane CholesterolMolecular Biology of the Cell, 2003
- Microvascular Hyperpermeability in Caveolin-1 (−/−) Knock-out MiceJournal of Biological Chemistry, 2002
- Lymphangiogenesis and cancer metastasisNature Reviews Cancer, 2002
- Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and AngiogenesisCell, 1999
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.Journal of Clinical Investigation, 1998
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997
- Dissecting the Interaction between Nitric Oxide Synthase (NOS) and CaveolinJournal of Biological Chemistry, 1997
- Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.Journal of Clinical Investigation, 1997
- Microvascular Perfusion during Focal Vasogenic Brain Edema: A Scanning Laser Fluorescence Microscopy StudyMicrovascular Research, 1997
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991